Clinical Trials on IOP Decreased in Switzerland

Total 9 results

University Hospital Inselspital, Berne

Completed

Perioperative Lung Function Monitoring After Anatomic Lung Resections (PLF)

Lung Diseases | Surgery | Lung Function Decreased

Switzerland
Centre Hospitalier Universitaire Vaudois

Not yet recruiting

Perioperative Smartwatch Monitoring to Predict Complications (PreSmart)

Post-Op Complication

Switzerland
University Hospital, Basel, Switzerland

Completed

Predictive Value of Heart Rate Variability on Cardiorespiratory Events

Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)

Switzerland
University Hospital, Geneva

Terminated

Prevalence of Trephined Syndrome After Decompressive Craniectomy (TS)

Stroke | Traumatic Brain Injury | Post-Op Complication | Post-Op Infection | Post Operative Hemorrhage | Trephined Syndrome | Sinking Skin Flap Syndrome

Switzerland
University Children's Hospital Basel
Novartis Pharmaceuticals; Stiftung zur Förderung medizinischer und biologischer... and other collaborators

Active, not recruiting

Immunomodulation With Eltrombopag in ITP (iROM2)

Primary Immune Thrombocytopenia (ITP)

Switzerland
Dr. Med Anas Taha
University of Basel; GZO Hospital, Zürich, Switzerland

Recruiting

Development of Machine Learning Models for the Prediction of BMI and Complications After Bariatric Surgery (CABS-Study)

Sleep Apnea, Obstructive | Diabetes Mellitus, Type 2 | Body Weight | Hiatal Hernia | Internal Hernia | GERD | Intussusception | Post-Op Complication | Anastomosis, Leaking | Mesenteric Hernia

Switzerland
European Research Consortium on ITP
Fondazione Progetto Ematologia

Completed

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Primary Immune Thrombocytopenia (ITP)

Spain, Switzerland, United Kingdom, Italy, France, Norway
Swedish Orphan Biovitrum

Active, not recruiting

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP (ADOPT)

Immune Thrombocytopenia | ITP

Croatia, Czechia, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP (TAPER)

Immune Thrombocytopenic Purpura (ITP)

Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States

Clinical Trials on IOP Decreased in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations